Liver International
- Risk of Hepatic and Extrahepatic Cancer in NAFLD
- Adherence to the DASH Diet and NAFLD
- Alcohol-related Hepatitis in the First Months of COVID-19
- Incidence of HCV Related HCC in the Era of IFN-free Therapies
- Immunosuppressive Drugs and COVID-19 Severity in AIH
- Assessing Liver Steatosis in the Obese Before Bariatric Surgery
- Glycosylated 4-methylumbelliferone as Targeted Therapy for HCC
- Long-Term Prognosis in Alcohol-related Liver Disease or NAFLD
- Epidemiological and Clinical Features of MAFLD and NAFLD
- Novel Quantitative Ultrasound Technique for Identifying NASH
- HCV Care: Targeting People With Diabetes, Hazardous Alcohol Use
- Binge Drinking and Fibrogenesis: More Than Just a Hangover
- Binge Drinking Induces Markers of Hepatic Fibrogenesis
- Waist and Hip Circumference and Risk of Liver Disease
- Association Between Circulating Bile Acid Alterations and NASH
- Impact of COVID-19-related Public Health Measures on HCV Testing
- HCC Risk in Hepatitis C Stage-3 Fibrosis After SVR With DAAs
- Peripheral Neuropathy After Viral Eradication in Chronic HCV
- COVID-19 and Metabolic-associated Liver Disease
- High Prevalence of Celiac Disease in Autoimmune Hepatitis